Advanced Wound Care Devices Market Report 2026

The advanced wound care devices market size has grown strongly in recent years. It will grow from $12.27 billion in 2025 to $13.03 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of chronic wounds, growing awareness of advanced wound care benefits, adoption of antimicrobial and hydrogel dressings, increasing hospital and clinic infrastructure, expansion of diabetic and geriatric patient base.

The advanced wound care devices market size is expected to see steady growth in the next few years. It will grow to $15.01 billion in 2030 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to technological advancements in tissue-engineered products, rising adoption of smart and bioactive dressings, increasing homecare and outpatient services, growth in healthcare expenditure, integration of infection prevention and skin protection technologies. Major trends in the forecast period include increasing adoption of hydrogel and bioactive dressings, rising use of antimicrobial gels and powders for chronic wounds, expansion of advanced foam and tissue-engineered products, growing focus on infection prevention and skin protection, increasing homecare and outpatient wound management solutions.

The rising number of surgeries is expected to drive the growth of the advanced wound care market in the coming years. A surgical procedure is a medical intervention that involves cutting or penetrating the body’s tissues to treat diseases, conditions, or injuries, or to modify bodily functions or improve appearance. Advanced wound care products support surgeries by promoting faster healing and reducing the risk of complications such as infections. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, liposuction remained the most popular plastic surgery procedure in 2023, with nearly 350,000 procedures performed, marking a 7% increase compared to 2022. Therefore, the increasing rate of surgeries is contributing to the growth of the advanced wound care market.

Major companies in the advanced wound care market are focusing on developing innovative technologies such as Aquacel Hydrofiber Technology to meet the needs of healthcare providers and patients. Aquacel Hydrofiber Technology is a soft, absorbent material that transforms into a gel upon contact with wound fluid. For instance, in January 2023, Convatec Group PLC, a UK-based medical device company, launched ConvaFoam, an advanced foam dressing. ConvaFoam is designed to address the growing challenge of hard-to-heal wounds, which pose significant economic, clinical, and social burdens. The product is the only foam dressing that combines superabsorbent fibers with AQUACEL Hydrofiber technology and is engineered to maximize wear time with a silicone adhesive that balances adhesive strength, skin-friendly adhesion, and breathability.

In May 2024, KKR, a US-based private equity and investment management firm, acquired Healthium MedTech for an undisclosed amount. Through this acquisition, KKR aims to strengthen its presence in the global healthcare sector by expanding technological capabilities in medical devices and capturing growth opportunities in the advanced wound care and surgical consumables markets. Healthium MedTech is an India-based medical device company providing advanced wound care products, surgical consumables, and infection prevention solutions.

Major companies operating in the advanced wound care devices market are 3M Company, Coloplast Corporation, ConvaTec Group plc, Smith & Nephew plc, Integra LifeSciences Corporation, Organogenesis Holdings Inc., Medtronic plc, MiMedx Group Inc., Derma Sciences Inc., Johnson & Johnson Private Limited, Mölnlycke Health Care AB, Cardinal Health Inc., B. Braun Melsungen AG, Baxter International, Acelity L.P. Inc., BSN Medical GmbH, Covidien plc, DeRoyal Industries Inc., Hollister Incorporated, Human Biosciences Inc., Kinetic Concepts Inc., Medline Industries Inc., Triage Meditech Pvt. Ltd., ACell Inc., Acera Surgical Inc., ACI Medical LLC, Advanced Oxygen Therapy Inc., Imbed Biosciences Inc., MolecuLight Inc., NuVision Biotherapies Ltd.

North America was the largest region in the advanced wound care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the advanced wound care market report during the forecast period. The regions covered in the advanced wound care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the advanced wound care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the advanced wound care devices market by increasing the cost of imported materials and specialized dressing components, affecting segments such as hydrogel dressings, antimicrobial gels, and tissue-engineered products. Regions like north america, europe, and asia-pacific, which rely heavily on imports for advanced wound care products, are most impacted. This has resulted in higher production costs and supply chain delays. On the positive side, tariffs have encouraged local manufacturing, innovation in product formulations, and investment in domestic production capacities.

The advanced wound care devices market research report is one of a series of new reports that provides advanced wound care devices market statistics, including advanced wound care devices industry global market size, regional shares, competitors with a advanced wound care devices market share, detailed advanced wound care devices market segments, market trends and opportunities, and any further data you may need to thrive in the advanced wound care devices industry. This advanced wound care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Advanced wound care involves the treatment of chronic or complicated wounds using products that are not typically available over the counter. It also offers benefits such as maintaining body temperature, protecting against infections, removing dead tissue, preventing scar formation, and reducing pain during dressing changes. It can promote healing in complex or hard-to-heal wounds.

The primary types of products utilized in advanced wound care include antimicrobial gels, antimicrobial powders, concentrated surfactants, hydrogel dressings, skin protectants, wound cleansers, semi-permeable film dressings, semi-permeable antimicrobial film dressings, semi-permeable non-antimicrobial film dressings, and others. Antimicrobial wound gels are water-based gel dressings applied to wounds to keep the area moist and support the healing process. The wounds treated include surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and more. These products are applied to both chronic and acute wounds, with the main end users being hospitals, clinics, home care environments, and other healthcare settings.

The advanced wound care market consists of sales of advanced wound dressings, and infection prevention dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.